ritlecitinib tosylate

Term ID

CHEBI:229234

Synonyms

1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one 4-methylbenzenesulfonate (1:1)
1-{(2S,5R)-2-methyl-5-[(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}prop-2-en-1-one 4 methylbenzene-1-sulfonic acid
4-methylbenzene-1-sulfonic acid--1-{(2S,5R)-2-methyl-5-[(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}prop-2-en-1-one (1/1)
Litfulo
PF-06651600 tosylate
ritlecitinib tosilate

Definition

An organosulfonate salt obtained by combining equimolar amounts of ritlecitinib and 4-toluenesulfonic acid. It is a kinase inhibitor, developed by Pfizer for the treatment of severe alopecia areata in adults and adolescents 12 years and older.

References

cas:2192215-81-7
drugbank:DBSALT003482
kegg.drug:D11970
pubmed:37556041
pubmed:37703124
pubmed:37983117
pubmed:38051245
pubmed:38051803

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from ritlecitinib tosylate

Phenotype where environments contain ritlecitinib tosylate

Phenotype modified by environments containing ritlecitinib tosylate

Phenotype affecting ritlecitinib tosylate

Human Disease Model